QY1

(2R)-cyclopentyl{4-[(quinolin-2-yl)methoxy]phenyl}acetic acid

Find entries where: QY1

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	(2R)-cyclopentyl{4-[(quinolin-2-yl)methoxy]phenyl}acetic acid
Identifiers	(2~{R})-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]ethanoic acid
Formula	C₂₃ H₂₃ N O₃
Molecular Weight	361.434
Type	NON-POLYMER
Isomeric SMILES	c1ccc2c(c1)ccc(n2)COc3ccc(cc3)[C@@H](C4CCCC4)C(=O)O
InChI	InChI=1S/C23H23NO3/c25-23(26)22(17-6-1-2-7-17)18-10-13-20(14-11-18)27-15-19-12-9-16-5-3-4-8-21(16)24-19/h3-5,8-14,17,22H,1-2,6-7,15H2,(H,25,26)/t22-/m1/s1
InChIKey	ZEYYDOLCHFETHQ-JOCHJYFZSA-N

Chemical Details
Formal Charge	0
Atom Count	50
Chiral Atom Count	1
Bond Count	53
Aromatic Bond Count	17

Drug Info: DrugBank

DrugBank ID	DB16346
Name	Veliflapon
Groups	investigational
Description	Veliflapon is under investigation in clinical trial NCT00353067 (Veliflapon (Dg-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina).
Synonyms	Veliflapon
Categories	Analgesics Analgesics, Non-Narcotic Anti-Inflammatory Agents Anti-Inflammatory Agents, Non-Steroidal Antirheumatic Agents Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Lipoxygenase Inhibitors Peripheral Nervous System Agents Sensory System Agents
CAS number	128253-31-6

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Arachidonate 5-lipoxygenase-activating protein	MDQETVGNVVLLAIVTLISVVQNGFFAHKVEHESRTQNGRSFQRTGTLAF...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682